Calculus bovis sativus (CBS)

DRUG4 trials

Sponsors

Tongji Hospital

Conditions

Acute Disseminated EncephalomyelitisAcute Ischemic StrokeAutoimmune EncephalitisAutoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor AntibodyBrain HemorrhageCerebral Small Vessel DiseasesEncephalitisEncephalitis, Viral

Unknown Phase

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)

RecruitingNCT06474507

Tongji HospitalAcute Ischemic Stroke, Cerebral Small Vessel Diseases, Ischemic Cerebrovascular Disease

Start: 2024-08-08End: 2029-12-31Target: 230Updated: 2024-09-20

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

RecruitingNCT06474520

Tongji HospitalAcute Disseminated Encephalomyelitis, Idiopathic Inflammatory Demyelinating Disease, Multiple Sclerosis +2

Start: 2024-08-08End: 2029-12-31Target: 250Updated: 2024-09-20

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

RecruitingNCT06584045

Tongji HospitalAutoimmune Encephalitis, Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody, Encephalitis +1

Start: 2024-09-30End: 2029-12-31Target: 250Updated: 2025-04-08

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Intracerebral Hemorrhage(CBSinICH)

Not yet recruitingNCT07080632

Tongji HospitalBrain Hemorrhage, Intracerebral Hemorrhage

Start: 2025-10-01End: 2027-01-01Target: 300Updated: 2025-10-01